Differential expression of CD147, CD44v3-10, MDR1, MCT1 and MCT4 also suggests that the phenotypes of CaP metastasis may be controlled by genetics and/or by the tumour microenvironment during CaP progression. This evidence concerns the gene BSG and neoplasm.